Methotrexate and leucovorin in malignant blood diseases
- 1 January 1991
- journal article
- Published by Elsevier in Bailliere's Clinical Haematology
- Vol. 4 (1) , 1-13
- https://doi.org/10.1016/s0950-3536(05)80282-3
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Human liver methenyltetrahydrofolate synthetase: improved purification and increased affinity for folate polyglutamate substratesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
- Clinical Pharmacodynamics of High-Dose Methotrexate in Acute Lymphocytic LeukemiaNew England Journal of Medicine, 1986
- Heterogeneity in the specific activity and methotrexate sensitivity of dihydrofolate reductase from blast cells of acute myelogenous leukemia patients.Journal of Clinical Oncology, 1985
- Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate.Journal of Clinical Investigation, 1985
- Polyglutamation of methotrexate. Is methotrexate a prodrug?Journal of Clinical Investigation, 1985
- Comparison of Intermediate-Dose Methotrexate with Cranial Irradiation for the Post-Induction Treatment of Acute Lymphocytic Leukemia in ChildrenNew England Journal of Medicine, 1983
- Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine.Journal of Clinical Oncology, 1983
- Inhibition of a methotrexate-insensitive dihydrofolate reductase from L5178Y cells by substituted triazines and quinazolinesBiochemical Pharmacology, 1983
- Ocular irritation from high-dose methotrexate therapy: Pharmacokinetics of drug in the tear filmCancer, 1981
- New Approaches to Cancer Chemotherapy with MethotrexateNew England Journal of Medicine, 1975